{"links":{"self":"https://clientapi.gcs-web.com/data/4273085b-1cd0-48e8-9d97-9b5b21faf122/events/23651"},"meta":{"executionDate":"2026-04-04T14:44:12","cmsDomain":"https://alnylampharmaceuticalsinc.gcs-web.com"},"data":{"id":23651,"title":"Alnylam Pharmaceuticals Conference Call to Discuss Results from ENVISION Phase 3 Study of Givosiran","type":{"title":"Conference Presentation","id":396},"categories":[{"title":"Default Calendar","id":3971}],"startDate":{"dateUTC":"2019-04-13T12:00:00","date":"2019-04-13T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"endDate":null,"isEstimated":false,"summary":null,"webCast":{"id":null,"source":"url","title":"Listen to Webcast","url":"https://event.webcasts.com/starthere.jsp?ei=1236641&tp_key=20c92a38d8"},"teleconference":null,"speakers":[],"location":null,"supportingMaterials":[],"thumbnail":null,"createdOnUTC":"2019-04-01T13:33:18","lastUpdatedUTC":"2019-04-13T12:02:07"},"error":null}